ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2256

Increased Brain Functional Connectivity to the Insula Is Associated with Nociplastic Pain in Psoriatic Arthritis

Flavia Sunzini1, Kristian Stefanov1, Salim Al-Wasity1, Steven E Harte2, Richard E Harris2, Daniel J Clauw2, Stefan Siebert3, Carl Goodyear1, Gordon Waiter4 and Neil Basu1, 1University of Glasgow, Glasgow, Scotland, United Kingdom, 2University of Michigan, Ann Arbor, MI, 3Institute of Infection, Immunity and Inflammation, University of Glasgow, Glasgow, Scotland, United Kingdom, 4University of Aberdeen, Aberdeen, Scotland, United Kingdom

Meeting: ACR Convergence 2022

Keywords: Brain, fibromyalgia, Neuroimaging, pain, Psoriatic arthritis

  • Tweet
  • Email
  • Print
Session Information

Date: Monday, November 14, 2022

Title: Abstracts: Spondyloarthritis Including PsA – Diagnosis, Manifestations, and Outcomes II: Imaging

Session Type: Abstract Session

Session Time: 4:30PM-6:00PM

Background/Purpose: Pain is a hallmark feature of psoriatic arthritis (PsA); however, its apparent multi-factorial nature makes it difficult for rheumatologists to assess and manage. Clinically, nociplastic processes appear to contribute to the PsA pain experience, as shown by frequent co-existing fibromyalgia (FM), a prototypical nociplastic pain disorder [1,2]. Yet there are no objective data to corroborate this observation. This is important to determine given the distinct nociplastic pain management compared to classical anti-inflammatory PsA therapies. Nociplastic pain is characterised by amplified central nervous system responses and altered functional brain connectivity demonstrated in several neuroimaging studies. In particular, the insular cortices (IC), which are the key sensory integrative hubs that capture and compute distinct dimensions of pain perception, have consistently displayed increased connectivity in several nociplastic pain conditions [3-6]. This is the first study to investigate such objective neurobiological markers of nociplastic pain in PsA.

Methods: PsA patients with active disease who fulfilled CASPAR criteria [7] were clinically characterised. Nociplastic pain was assessed using the ACR 2011 FM Survey criteria [8] before undertaking a 6-minute functional MRI scan. Images were acquired by a 3 Tesla, 32 channel phased array head coil using a T2*-weighted gradient-echo echo-planar imaging pulse sequence. Functional MRI data were analyzed using the functional connectivity CONN toolbox, based on SPM12 and ran on MATLAB R2019b. Bilateral subdivisions of the IC: anterior (ant), middle (mid) and posterior (post) IC, were our selected regions of interest (ROI). ROI to whole brain functional connectivity was estimated for each patient followed by group level multiple linear regression which correlated ROIs connectivity to our measure of nociplastic pain while correcting for age, sex and multiple comparisons (FDR < 0.05). Pearson correlations were additionally conducted (Tab. 1). Clinical data were analysed using simple descriptive statistics.

Results: 46 out of 50 patients enrolled, completed the functional MRI scan (mean age 49; 54% female; mean disease duration 7 years; mean ACR FM score 12.6 ±5.9; mean DAPSA 41.8 ±20). Of these, 41% fulfilled FM criteria. PsA patients with higher FM scores displayed increased connectivity between: 1) right mid IC to left anterior prefrontal cortex (R = 0.54, p ≤ 0.001) and bilateral parahippocampal gyrus (right R = 0.56, p ≤ 0.001, left R = 0.62, p ≤ 0.001); 2) right post IC to right thalamus (R = 0.62 p ≤ 0.001); 3) left post IC to right parahippocampal gyrus (R = 0.61, p ≤ 0.001) (Fig.1; Fig.2; Tab. 1).

Conclusion: For the first time, we report neurobiological evidence of nociplastic pain in PsA. Increased functional brain connectivity between the mid-posterior IC (right more than left) and brain areas involved in sensory (thalamus), learning/affective (parahippocampal gyrus), and cognitive (prefrontal cortex) pain modulation is demonstrated. PsA should be considered a mixed-pain state. Rheumatologists should assess for nociplastic pain in PsA and adjust their management approach accordingly.

Supporting image 1

Location and connectivity to right and left insula cortices in PsA patients with higher degree of nociplastic pain. PFC, Prefrontal Cortex.

Supporting image 2

Pearson correlations between connectivity to Insula cortices and fibromyalgia score.
RpIC – right posterior Insula cortex; RmidIC – right middle Insula cortex; LpIC – left posterior Insula cortex; FDR – False Discovery Rate.

Supporting image 3


Disclosures: F. Sunzini, None; K. Stefanov, None; S. Al-Wasity, None; S. Harte, Aptinyx, Inc; R. Harris, None; D. Clauw, Tonix, Lundbeck, Pfizer, Eli Lilly, Samumed, Virios, Aptinyx, Teva; S. Siebert, AbbVie, Amgen, Boehringer Ingelheim, Bristol Myers Squibb, GSK, Janssen, Novartis, UCB, Biogen; C. Goodyear, None; G. Waiter, None; N. Basu, Vifor, Pfizer, GSK, Nesos, Lilly, Roche, AbbVie, MSD, Galapagos.

To cite this abstract in AMA style:

Sunzini F, Stefanov K, Al-Wasity S, Harte S, Harris R, Clauw D, Siebert S, Goodyear C, Waiter G, Basu N. Increased Brain Functional Connectivity to the Insula Is Associated with Nociplastic Pain in Psoriatic Arthritis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/increased-brain-functional-connectivity-to-the-insula-is-associated-with-nociplastic-pain-in-psoriatic-arthritis/. Accessed .
  • Tweet
  • Email
  • Print

« Back to ACR Convergence 2022

ACR Meeting Abstracts - https://acrabstracts.org/abstract/increased-brain-functional-connectivity-to-the-insula-is-associated-with-nociplastic-pain-in-psoriatic-arthritis/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology